Comment on

• Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study.

  Pokrajac B, Pötter R, Wolfram RM, Budinsky AC, Kirisits C, Lileg B, Mendel H, Sabeti S, Schmid R, Minar E. Pokrajac B, et al. Radiother Oncol. 2005 Jan;74(1):3-9. doi: 10.1016/j.radonc.2004.08.015. Radiother Oncol. 2005. PMID: 15683661 Clinical Trial.
• External beam radiation therapy reduces the rate of re-stenosis in patients treated with femoral stenting: results of a randomised study.

  Zabakis P, Kardamakis DM, Siablis D, Kalogeropoulou C, Karnabatidis D, Malatara G, Dimopoulos IA. Zabakis P, et al. Radiother Oncol. 2005 Jan;74(1):11-6. doi: 10.1016/j.radonc.2004.09.010. Radiother Oncol. 2005. PMID: 15683662 Clinical Trial.
• Outcome of radiation therapy for renal transplant rejection refractory to chemical immunosuppression.

  Nuyttens JJ, Harper J, Jenrette JM, Turrisi AT 3rd. Nuyttens JJ, et al. Radiother Oncol. 2005 Jan;74(1):17-9. doi: 10.1016/j.radonc.2004.08.011. Radiother Oncol. 2005. PMID: 15683663 Clinical Trial.
• Radiation therapy in cancer patients with psoriasis. The fractionated daily dose and the Koebner phenomenon.

  Ben-Yosef R, Soyfer V, Vexler A. Ben-Yosef R, et al. Radiother Oncol. 2005 Jan;74(1):21-3. doi: 10.1016/j.radonc.2004.08.019. Radiother Oncol. 2005. PMID: 15683664
• Long term results of non-surgical, exclusive strontium-/yttrium-90 beta-irradiation of pterygia.

  Pajic B, Greiner RH. Pajic B, et al. Radiother Oncol. 2005 Jan;74(1):25-9. doi: 10.1016/j.radonc.2004.08.022. Radiother Oncol. 2005. PMID: 15683665 Clinical Trial.